Patents by Inventor Yehuda VAZANA

Yehuda VAZANA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220133650
    Abstract: A combination therapy, comprising a pharmaceutical composition of an N-Methyl D-Aspartate receptor (NMDA) receptor blocker and a Transforming Growth Factor beta (TGF-?) receptor antagonist, for treatment of brain diseases associated with BBB dysfunction.
    Type: Application
    Filed: February 6, 2020
    Publication date: May 5, 2022
    Inventors: Alon FRIEDMAN, Ofer PRAGER, Yehuda VAZANA
  • Publication number: 20180214462
    Abstract: Provided are compositions which include N-methyl-d-aspartate receptor (NMDA-R) antagonists. Moreover, provided are methods for reducing the permeability of the blood-brain-barrier, in a patient, by administering to the patient, a composition which includes N-methyl-d-aspartate receptor (NMDA-R) antagonists.
    Type: Application
    Filed: July 27, 2016
    Publication date: August 2, 2018
    Inventors: Alon FRIEDMAN, Yehuda VAZANA